Creating a National Infectious Diseases Institute in Tanzania
Official title: Transitioning to a National Infectious Diseases Institute in Tanzania
Funded at University of Virginia · NIH-11054691 · Data updated 2026-11-12
This study is all about helping the Kibong’oto Infectious Diseases Hospital in Tanzania become a top-notch center for research on diseases like HIV and tuberculosis by building a strong team to support research and training, so they can better serve patients and improve health outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project start | April 1, 2024 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $102,039 |
| NIH project number | 5G11TW012747-02 |
| Project ID | NIH-11054691 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with HIV or tuberculosis in Tanzania who may benefit from improved healthcare infrastructure and research advancements.
✕Less likely to help
Patients outside of Tanzania or those not affected by HIV or tuberculosis may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing the capabilities of the Kibong’oto Infectious Diseases Hospital in Tanzania as it transitions into a National Infectious Diseases Institute. It aims to develop a robust research administration office and establish a training program to improve research practices. By addressing the needs identified through a formal assessment, the project seeks to strengthen the hospital's ability to manage and conduct research on HIV, tuberculosis, and other infectious diseases. This initiative will involve collaboration with local and regional organizations to ensure sustainability and effectiveness.
Why it matters
Potential benefit: If successful, this research could significantly improve the management and treatment of infectious diseases in Tanzania, particularly for patients with HIV and tuberculosis.
How similar studies have gone: Similar initiatives have shown promise in enhancing healthcare infrastructure and research capabilities in other regions, indicating a potential for success in this novel approach.
Where this research is happening
-
University of Virginia
Charlottesville, United States Active
Researchers
- Principal investigator: Steen, Amber — University of Virginia
- Study coordinator: Steen, Amber
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.